Nasdaq Biotechnology Ishares (IBB) 351.32 $IBB Biotech

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Nasdaq Biotechnology Ishares (IBB) 351.32 $IBB

Biotech Weekly: Top Value Biotech Picks Starting Q2 2015
Daniel Ward - at Seeking Alpha - Mon Mar 30, 8:43AM CDT

LOXO: 12.55 (+0.19), TENX: 3.14 (unch), QLTI: 3.93 (+0.10), ECYT: 6.29 (-0.07), TNXP: 6.27 (+0.15), BOTA: 2.26 (-0.01), XBI: 224.37 (+4.96), DARA: 0.76 (-0.03), IBB: 351.32 (+3.86), MEIP: 1.75 (+0.01)

Is Gilead Sciences Inc. About to Crater Before Our Very Eyes?
George Budwell, The Motley Fool - Motley Fool - Sun Mar 29, 9:02AM CDT
Gilead Sciences ' stock has been something of an enigma for biotech investors of late. Despite a 122% increase in revenue last year due primarily to the launch of its hepatitis C drugs Sovaldi and Harvoni, strong growth prospects going forward, and...
GILD: 100.69 (-0.31), ACHN: 10.24 (+0.08), MRK: 58.34 (+0.59), IBB: 351.32 (+3.86), ABBV: 58.24 (+0.59)

The 'End Game' - My Take On Indicators Leading To The End Of The U.S. Bull Market
Robert Duval - at Seeking Alpha - Sun Mar 29, 2:53AM CDT

SPY: 208.25 (+2.51), QQQ: 106.73 (+1.21), DIA: 179.39 (+2.58), IBB: 351.32 (+3.86), IWM: 124.77 (+1.67)

Weighing The Week Ahead: Time For An Economic Spring Thaw?
Jeff Miller - Seeking Alpha - Sun Mar 29, 12:57AM CDT
In the absence of real data it is easy and tempting to speculate. Unlike last week, the week ahead features an avalanche of data - more in both quantity and importance than we have seen in a month. With some recent significant reports showing...
IBB: 351.32 (+3.86), SPUU: 144.18 (+3.58), SPLX: 31.76 (+0.67), TQQQ: 106.28 (+3.69), SDOW: 19.12 (-0.88), DOG: 22.82 (-0.34), SPXU: 35.07 (-1.33), UPRO: 137.02 (+4.88), SPY: 208.25 (+2.51), EPS: 72.10 (+1.06), DXD: 20.83 (-0.65), QQXT: 41.81 (+0.41), SQQQ: 25.92 (-0.95), DIA: 179.39 (+2.58), SPXL: 90.80 (+3.24), QID: 36.08 (-0.87), SFLA: 159.00 (unch), RWL: 41.71 (+0.57), RSP: 81.61 (+0.95), SH: 21.27 (-0.27), SSO: 131.64 (+3.16), QQEW: 44.23 (+0.56), IVV: 209.62 (+2.52), QQQE: 65.83 (+0.80), DDM: 136.96 (+3.98), QLD: 145.90 (+3.47), VOO: 190.88 (+2.35), QQQ: 106.73 (+1.21), SDS: 20.96 (-0.53), PSQ: 56.96 (-0.68), UDOW: 144.22 (+6.12)

Stocks Finish Lower for the Week as Fed Talk Spooks Investors
at The Street - Fri Mar 27, 3:20PM CDT
Wall Street ends its four-day losing streak on Friday, but the minor gains are nowhere near enough to erase big losses suffered over the week.
BIIB: 431.62 (+1.75), VRTX: 121.25 (+0.91), BMRN: 129.13 (+0.35), MON: 113.38 (+0.65), IBB: 351.32 (+3.86), SOXX: 95.09 (+1.20), NXPI: 102.43 (+2.51), KMX: 69.22 (+2.53), AYI: 172.57 (+4.57), AA: 12.96 (+0.26), TXN: 58.00 (+1.24), ADI: 64.81 (+5.97), ALXN: 180.26 (-0.33), AVGO: 130.55 (+2.34), REGN: 459.78 (+5.28)

Stock Markets Hold Onto Slight Gains Ahead of Yellen Speech
at The Street - Fri Mar 27, 2:11PM CDT
Stocks inch higher on Friday afternoon, recovering from an earlier drop.
BIIB: 431.62 (+1.75), VRTX: 121.25 (+0.91), BMRN: 129.13 (+0.35), GME: 37.69 (-0.67), OLN: 32.41 (+1.41), BBRY: 8.80 (-0.66), IBB: 351.32 (+3.86), HPQ: 31.57 (+0.08), YHOO: 44.95 (-0.15), ALXN: 180.26 (-0.33), DOW: 48.68 (+0.92), REGN: 459.78 (+5.28)

Young Investors Should Hope for a Pullback Sooner Rather Than Later
at The Street - Fri Mar 27, 1:53PM CDT
The CNBC 'Fast Money Halftime' traders discuss attributes young investors should look to develop for the markets, while a market pro weighs in with his top picks.
AMZN: 374.59 (+4.03), ZIOP: 11.61 (+0.17), XBI: 224.37 (+4.96), IBB: 351.32 (+3.86), INXN: 28.06 (-0.87), TLT: 130.41 (-0.65), TBT: 42.07 (+0.39), LEN: 51.49 (+1.06), SPY: 208.25 (+2.51), QQQ: 106.73 (+1.21), XHB: 36.85 (+0.65), P: 16.39 (+0.07), GILD: 100.69 (-0.31), KITE: 59.98 (+0.20), PHM: 22.44 (+0.42), DIA: 179.39 (+2.58), ITB: 28.26 (+0.47), JUNO: 60.75 (+4.15), IWM: 124.77 (+1.67), KBH: 15.66 (+0.38), AAPL: 126.37 (+3.12), ZU: 13.37 (+0.44), BABA: 83.90 (-0.68)

A Buyback Or Biotech Bubble?
Leo Kolivakis - Seeking Alpha - Fri Mar 27, 1:37PM CDT
(click to enlarge) Steven Davidoff Solomon, professor of law at the University of California, Berkeley, wrote a comment for the New York Times reports, General Motors' Stock Buyback Follows a Worrying Trend : General Motors' announcement that...
BIIB: 431.62 (+1.75), GILD: 100.69 (-0.31), XBI: 224.37 (+4.96), IBB: 351.32 (+3.86), PKW: 49.69 (+0.67), CELG: 120.02 (+1.34)

Biotech’s Busted — Here’s What To Do Now…
Greg Guenthner - Daily Reckoning - Fri Mar 27, 10:41AM CDT
This post Biotech’s Busted — Here’s What To Do Now… appeared first on Daily Reckoning . Biotechs blasted lower all week. Semiconductors hit the mat. And the once high-flying Nasdaq lost more than 3% as of yesterday—topping off its worst...
IBB: 351.32 (+3.86), IWM: 124.77 (+1.67), XLV: 73.78 (+0.74)

Jim Cramer -- There's No Bubble in Biotech or Semiconductor Sectors
at The Street - Fri Mar 27, 10:23AM CDT
Some of Cramer's favorite companies are rising with their sectors Friday.
BIIB: 431.62 (+1.75), QRVO: 81.40 (+2.12), SWKS: 100.13 (+1.30), IBB: 351.32 (+3.86), SMH: 55.86 (+0.47), NXPI: 102.43 (+2.51), REGN: 459.78 (+5.28), AVGO: 130.55 (+2.34), CELG: 120.02 (+1.34)

Pharmacyclics, BioMarin, And Incyte: A Quick Screen
William Meyers - at Seeking Alpha - Thu Mar 26, 4:30PM CDT

PCYC: 256.43 (-0.12), BMRN: 129.13 (+0.35), INCY: 94.19 (-0.17), IBB: 351.32 (+3.86)

'Fast Money' Recap: ‘Nervousness’ Surrounds Quarterly Earnings Results
at The Street - Thu Mar 26, 1:57PM CDT
The CNBC ‘Fast Money Halftime’ traders analyze earnings and the impact of the strong dollar, as well as the unrest in the Middle East and SanDisk’s lowered guidance.
MU: 26.68 (+0.01), QCOM: 68.88 (+1.85), IBB: 351.32 (+3.86), INTC: 31.46 (-0.54), SNDK: 64.98 (+0.39)

Stocks Turn Flat in Bumpy Session; Crude Settles Above $51
at The Street - Thu Mar 26, 1:53PM CDT
Stocks recover from heavy losses suffered earlier Thursday.
IBB: 351.32 (+3.86), MYL: 60.00 (-1.63), LULU: 64.83 (+0.51), SLB: 84.48 (+1.17), CELG: 120.02 (+1.34), GILD: 100.69 (-0.31), ALXN: 180.26 (-0.33), RHT: 76.69 (+0.17), TWC: 149.27 (+1.99), CMCSA: 56.61 (+0.67)

ACADIA Pharmaceuticals At $30: The Upside Doesn't Justify The Risk
Edward Vranic, CFA - at Seeking Alpha - Thu Mar 26, 12:22PM CDT

ACAD: 33.35 (+1.39), IBB: 351.32 (+3.86)

BIS vs. IBB is The 'Chart of the Day'
at The Street - Thu Mar 26, 9:14AM CDT
The BIS vs. IBB is the OptionsProfits 'Chart of the Day.'
BIS: 32.99 (-0.80), IBB: 351.32 (+3.86)

Today's Market: Biotech Correction, Social Media News And Geopolitical Events Moving Stocks
Matthew Smith - at Seeking Alpha - Thu Mar 26, 9:10AM CDT

YHOO: 44.95 (-0.15), BIIB: 431.62 (+1.75), GILD: 100.69 (-0.31), FB: 83.19 (-0.11), XBI: 224.37 (+4.96), IBB: 351.32 (+3.86), AMGN: 164.30 (+1.71), GOOGL: 561.13 (+3.58), TWTR: 49.89 (-0.12), GOOG: 552.03 (+3.69), CELG: 120.02 (+1.34)

Biotech Stocks Are Selling Off Just Like 2014 -- and That Might Be a Good Thing
at The Street - Thu Mar 26, 6:17AM CDT
If history repeats itself, the recent weakness in biotech stocks will end with lots more buying.
PCYC: 256.43 (-0.12), XBI: 224.37 (+4.96), ITMN: 73.89 (-0.02), NPSP: 45.97 (+0.01), IBB: 351.32 (+3.86)

'Fast Money' Recap: The 3 Reasons Stocks Tanked Wednesday
at The Street - Thu Mar 26, 4:00AM CDT
The trading panel discussed the declines in biotech, transports and semiconductors.
FDX: 166.75 (+2.16), BIIB: 431.62 (+1.75), MU: 26.68 (+0.01), OIH: 33.90 (+0.32), XBI: 224.37 (+4.96), AMGN: 164.30 (+1.71), BNO: 20.93 (+0.06), IBB: 351.32 (+3.86), SMH: 55.86 (+0.47), INTC: 31.46 (-0.54), TLT: 130.41 (-0.65), CELG: 120.02 (+1.34), NVDA: 21.47 (+0.09), SAN: 7.50 (+0.03), SAVE: 78.30 (+1.66), GILD: 100.69 (-0.31), QCOM: 68.88 (+1.85), IYT: 157.46 (+1.46)

SmarTrend Watching for Potential Rebound in Shares of iShares Nasdaq Biotechnology Index After 4.12% Loss
Comtex SmarTrend(R) - Wed Mar 25, 3:50PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $340.76 to a high of $358.84. Yesterday, the shares fell 4.1%, which took the trading range below the 3-day low of $355.72 on volume of 4.8 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
IBB: 351.32 (+3.86)

iShares Nasdaq Biotechnology Index Falls 4.12% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Wed Mar 25, 3:49PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $340.76 to a high of $358.84. Yesterday, the shares fell 4.1%, which took the trading range below the 3-day low of $355.72 on volume of 4.8 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
IBB: 351.32 (+3.86)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Home Buying: Unmasking All the Real Budget Costs

Updated Category News Views 13

Home Buying: More Costs Than Meets the Eye Let's face it, buying a home is no stroll in the park. It's a tangled web of numbers and surprises that can leave even the savviest buyer in a daze. Thank goodness for articles like the one from HelloNation featuring Serena LoPiccolo-Smith, which make the invisible visible when it comes to the financial intricacies of home...

Continue Reading
Trial for Former OB/GYN Arthur Park Begins in Bakersfield

Updated Category News Views 10

A Somber Day for Justice in Bakersfield There’s a buzz in the air, thick with anticipation and grief, as a trial seven years in the making kicks off in Bakersfield. It’s a significant affair, marking a turning point in a saga that’s shadowed the region with untold grief and unresolved accountability. We’re talking about the trial of Arthur Park, a former OB/GYN,...

Continue Reading
Paradigm Therapeutics: A Beacon in Rare Diseases

Updated Category News Views 4

A Step Towards Recognition You know the old saying: innovation never sleeps. Well, Paradigm Therapeutics seems to have taken that to heart. The company's embarked on a peculiar yet promising journey with SD-101 (Zorblesia™), and here they are, basking in the glow of another nomination for the 2026 Prix Galien USA "Best Start-Up" award. It’s their second shot at this...

Continue Reading
Coventry's Jacobs Joins European Life Settlement Execs

Updated Category News Views 30

Neal Jacobs Steps Up in Life Settlements Coventry has added another feather to its cap with Neal Jacobs, their Senior Managing Director of Capital Markets, joining the Executive Committee of the European Life Settlement Association (ELSA). Elected at ELSA's Annual General Meeting on September 15, 2026, Jacobs brings a wealth of experience that promises to bolster the...

Continue Reading
Laars Welcomes Women in Manufacturing to Facility Tour

Updated Category News Views 12

Opening Doors and Minds in Manufacturing On October 15, Laars Heating Systems throws wide open its Rochester, N.H., facility to a group that's rewriting the rulebook: women in manufacturing. It's not just another day in the life of assembly lines and engineering desks, folks. This is about giving a platform to those often sidelined in the field of boilers and water...

Continue Reading
VetsinTech's AI Training Boosts Military Careers

Updated Category News Views 41

A New Spin on Engineering Careers Sometimes it feels like every corner I turn in this market maze, there’s something about AI. It’s not just chirping in the tech world anymore; it’s banging on the doors of sectors like engineering, aerospace, and manufacturing. And now, VetsinTech is tossing its hat into the AI ring with a fresh program aimed at blending military...

Continue Reading
Skiptown Expands in Georgia Amid Growing Demand

Updated Category News Views 25

With the pet care industry barking up a storm lately, Skiptown is ramping up efforts to expand its presence in Georgia. The tech-enabled dog care franchise already has a paw print in Atlanta, but it's sniffing out new opportunities across the state. Now they're on the hunt for franchise owners who can bring this modern approach to more communities. Why Georgia? The Growth...

Continue Reading
Think Tank Pushes for Bold Parkinson's Prevention Plan

Updated Category News Views 26

A New Era for Parkinson's Disease Prevention The Parkinson's Foundation has rolled out its battle plan to take on Parkinson's disease from the ground up, shifting gears from managing symptoms to stopping the illness before it starts. It's about damn time, too. With the disease being the fastest-growing neurodegenerative disorder and impacting 10 million people worldwide,...

Continue Reading
Veterans Transitioning to Real Estate with Scholarships

Updated Category News Views 15

Tapping Military Skills for Civilian Gain Finding a new career after military service is a mountain of a task, but veterans now have a golden ticket into the real estate appraisal world. The Appraisal Institute's Next Mission Scholarship is throwing veterans a $1,000 life preserver to dive into a field where their military-honed skills already shine. The Power of a...

Continue Reading
TechCrunch Disrupt 2026: NYSE and Snowflake Highlights

Updated Category News Views 28

Ever noticed how the air vibrates just a bit more when major players like NYSE and Snowflake start shaking hands at big-league events like TechCrunch Disrupt? You'd better believe we're seeing a fresh brew of opportunities and challenges in the market as these titans lock horns and share insights. It's no small feat when the financial nerve center partners into the tech...

Continue Reading

Top 5 Most Recently Viewed Articles

Stride's Major Setbacks: The Ghost Student Controversy Revealed

Updated Category News Views 159

Overview of Stride's Challenges Stride, Inc. (NYSE: LRN), a company involved in online education, is currently facing significant scrutiny due to serious allegations surrounding fraudulent practices and operational failures. Investors have been hit hard, with reports highlighting drastic drops in stock value following revelations of purported misconduct. The Allegations...

Continue Reading
Voltalia Breaks Ground on First Colombian Solar Project

Updated Category News Views 385

Voltalia Commences Solar Project in Colombia Voltalia, a notable force in renewable energy, has proudly announced the commencement of its inaugural solar power plant in Colombia, marking a significant milestone in its international projects. This ambitious venture, known as the Los Venados project, will harness a capacity of 19.7 megawatts through the use of over 33,000...

Continue Reading
Brooks and FP Movement Unite for Exclusive Footwear Line

Updated Category News Views 28

A Wild Step: Brooks Teams with FP Movement Sometimes, popsicles in August ain't just about cooling down; they're about making things sizzle. FP Movement and Brooks are coming in hot with their new exclusive sneaker lineup, aiming to shake up the treadmill warriors and track loungers alike. It's a collection that’s as stylish as your favorite sundress but is also tough...

Continue Reading
GERS Launches to Revolutionize Geospatial Data Integration

Updated Category News Views 275

Introducing the Global Entity Reference System (GERS) Overture Maps Foundation is proud to unveil GERS, a game-changing system for establishing unique identifiers for geospatial entities. This innovative approach significantly eases data connectivity across various platforms, facilitating easier interactions in sectors like automotive navigation, urban planning, and...

Continue Reading
Understanding Short Interests: The Taysha Gene Therapies Insight

Updated Category News Views 196

Current Market Sentiment of Taysha Gene Therapies The short interest for Taysha Gene Therapies has notably increased, showing a rise of 12.01% since the most recent report. As per the latest figures, approximately 40.78 million shares are now sold short, accounting for 16.7% of all shares available for trading. This increase means that, at the current trading volume, it...

Continue Reading